These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 19060472

  • 1. A severe and refractory case of anti-p200 pemphigoid resulting in multiple skin ulcers and scar formation.
    Goto-Ohguchi Y, Nishie W, Akiyama M, Tateishi Y, Aoyagi S, Tsuji-Abe Y, Sawamura D, Ishii N, Hashimoto T, Shimizu H.
    Dermatology; 2009; 218(3):265-71. PubMed ID: 19060472
    [Abstract] [Full Text] [Related]

  • 2. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
    Kasperkiewicz M, Hoppe U, Zillikens D, Schmidt E.
    Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
    [Abstract] [Full Text] [Related]

  • 3. Histopathology of anti-p200 pemphigoid.
    Rose C, Weyers W, Denisjuk N, Hillen U, Zillikens D, Shimanovich I.
    Am J Dermatopathol; 2007 Apr; 29(2):119-24. PubMed ID: 17414431
    [Abstract] [Full Text] [Related]

  • 4. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
    Shimanovich I, Petersen EE, Weyers W, Sitaru C, Zillikens D.
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
    [Abstract] [Full Text] [Related]

  • 5. Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?
    Shipman AR, Cooper S, Wojnarowska F.
    Clin Exp Dermatol; 2011 Apr; 36(3):267-9. PubMed ID: 20569254
    [Abstract] [Full Text] [Related]

  • 6. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
    Dainichi T, Koga H, Tsuji T, Ishii N, Ohyama B, Ueda A, Natsuaki Y, Karashima T, Nakama T, Yasumoto S, Zillikens D, Hashimoto T.
    J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
    [Abstract] [Full Text] [Related]

  • 7. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.
    Dilling A, Rose C, Hashimoto T, Zillikens D, Shimanovich I.
    J Dermatol; 2007 Jan; 34(1):1-8. PubMed ID: 17204094
    [Abstract] [Full Text] [Related]

  • 8. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
    Izumi R, Fujimoto M, Yazawa N, Nakashima H, Asashima N, Watanabe R, Kuwano Y, Kurokawa M, Hashimoto T, Tamaki K.
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
    [Abstract] [Full Text] [Related]

  • 9. Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption.
    Herrero-González JE, Sitaru C, Klinker E, Bröcker EB, Zillikens D.
    Clin Exp Dermatol; 2005 Sep; 30(5):519-22. PubMed ID: 16045683
    [Abstract] [Full Text] [Related]

  • 10. Localized linear IgA/IgG bullous dermatosis.
    Shimizu S, Natsuga K, Shinkuma S, Yasui C, Tsuchiya K, Shimizu H.
    Acta Derm Venereol; 2010 Nov; 90(6):621-4. PubMed ID: 21057747
    [Abstract] [Full Text] [Related]

  • 11. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.
    Groth S, Recke A, Vafia K, Ludwig RJ, Hashimoto T, Zillikens D, Schmidt E.
    Br J Dermatol; 2011 Jan; 164(1):76-82. PubMed ID: 20854435
    [Abstract] [Full Text] [Related]

  • 12. Parallel fluctuation of anti-desmoglein 3 and anti-BP180 autoantibody titres in a patient with bullous pemphigoid.
    Takahashi H, Anzai H, Suzuki Y, Tanikawa A, Amagai M, Nishikawa T.
    Clin Exp Dermatol; 2004 Nov; 29(6):608-11. PubMed ID: 15550133
    [Abstract] [Full Text] [Related]

  • 13. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?
    Wilczek A, Sticherling M.
    Int J Dermatol; 2006 Nov; 45(11):1353-7. PubMed ID: 17076725
    [Abstract] [Full Text] [Related]

  • 14. Pathogenesis of bullous pemphigoid.
    Ujiie H, Nishie W, Shimizu H.
    Dermatol Clin; 2011 Jul; 29(3):439-46, ix. PubMed ID: 21605809
    [Abstract] [Full Text] [Related]

  • 15. Case of papuloerythroderma of Ofuji-like eruption during the course of bullous pemphigoid.
    Hayakawa-Asai R, Nobeyama Y, Maki T, Asahina A, Nakagawa H.
    J Dermatol; 2018 Mar; 45(3):e63-e64. PubMed ID: 29205461
    [No Abstract] [Full Text] [Related]

  • 16. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M.
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [Abstract] [Full Text] [Related]

  • 17. Case of subepidermal autoimmune bullous disease with psoriasis vulgaris reacting to both BP180 C-terminal domain and laminin gamma-1.
    Ishida S, Takahashi K, Kanaoka M, Okawa T, Tateishi C, Yasukochi A, Ishii N, Li X, Hashimoto T, Aihara M.
    J Dermatol; 2015 Apr; 42(4):391-3. PubMed ID: 25683229
    [Abstract] [Full Text] [Related]

  • 18. Lichen planus pemphigoides: detection of anti-BP 180 antibodies by ELISA and immunoblotting tests.
    Barnadas MA, Roé E, Dalmau J, Alomar A, Martínez L, Gelpí C.
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1360-1. PubMed ID: 20337815
    [No Abstract] [Full Text] [Related]

  • 19. Absence of anti-BP180 antibodies in mothers of infants with bullous pemphigoid.
    Chiavérini C, Hamel-Teillac D, Gilbert D, Prost Y.
    Br J Dermatol; 2006 May; 154(5):839-43. PubMed ID: 16634883
    [Abstract] [Full Text] [Related]

  • 20. Anti-p200 pemphigoid.
    Goletz S, Hashimoto T, Zillikens D, Schmidt E.
    J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.